|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
EGYPTIAN INT. PHARM. IND. COMPANY
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Dehydration |
|
Diarrhea, parasite-associated, suspected |
|
>> Dysentery, acute, characterized by bloody stools and elevated temperature |
|
|
ADULT DOSE:
|
|
Antidiarrheal-
Oral, 60 to 120 mL after each loose bowel movement. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Antidiarrheal-
Children up to 3 years of age: Use is not recommended unless directed by a physician.
Children 3 to 6 years of age: Oral, 15 to 30 mL after each loose bowel movement.
Children 6 to 12 years of age: Oral, 30 to 60 mL after each loose bowel movement.
Children 12 years of age and over: Oral, 45 to 60 mL after each loose bowel movement.
Note: In general, dietary treatment of diarrhea in children is preferred whenever possible. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|